Study Protocol for MS tolDC: a phase I clinical trial of a personalized 'Negative' dendritic cell-based vaccine for the treatment of multiple sclerosis

  • B. Willekens
  • , J. Derdelinckx
  • , P. Cras
  • , P. Parizel
  • , E. Martinez-Caceres
  • , C. Ramo-Tello
  • , W. Van Hecke
  • , A. Ribbens
  • , Z. Berneman
  • , N. Cools

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)777-777
Number of pages1
JournalMultiple Sclerosis Journal
Volume22
Publication statusPublished - Sept 2016
Externally publishedYes
Event32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) - London
Duration: 14 Sept 201617 Sept 2016

Cite this